» Articles » PMID: 33231844

A Positive Feedback Loop Between AlkB Homolog 5 and MiR-193a-3p Promotes Growth and Metastasis in Esophageal Squamous Cell Carcinoma

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2020 Nov 24
PMID 33231844
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignancies worldwide. miR-193a-3p acts as an oncogene or tumor suppressor in different cancers. However, the functional role and regulatory mechanism of miR-193a-3p in ESCC remain to be elucidated. Our results demonstrated that miR-193a-3p expression was significantly upregulated and associated with advanced TNM stage, recurrence, and poor prognosis in ESCC patients. miR-193-3p targeted ALKBH5 and suppressed its expression. ALKBH5 inhibited miR-193a-3p expression in turn. ALKBH5 affected the primary miR-193a-3p processing by negatively regulating its mA modification. These findings suggested a positive feedback regulation between miR-193a-3p and ALKBH5 in ESCC cells. Moreover, the functional assays indicated that the miR-193-3p-ALKBH5 feedback loop promoted the proliferation, migration and invasion ability of ESCC cells in vitro, and facilitated tumor growth and metastasis in vivo. Collectively, our current study identified a novel positive feedback regulation between miR-193a-3p and ALKBH5 in ESCC, which may be helpful to gain insight into ESCC pathogenesis and provide novel therapeutic target for ESCC.

Citing Articles

Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications.

He Z, Ji Y, Yuan Y, Liang T, Liu C, Jiao Y Front Pharmacol. 2025; 16:1532558.

PMID: 39944625 PMC: 11814179. DOI: 10.3389/fphar.2025.1532558.


Role of the mA demethylase ALKBH5 in gastrointestinal tract cancer (Review).

Zhang L, Jing M, Song Q, Ouyang Y, Pang Y, Ye X Int J Mol Med. 2024; 55(2).

PMID: 39611478 PMC: 11637504. DOI: 10.3892/ijmm.2024.5463.


Ramifications of m6A Modification on ncRNAs in Cancer.

Mehmood R Curr Genomics. 2024; 25(3):158-170.

PMID: 39087001 PMC: 11288162. DOI: 10.2174/0113892029296712240405053201.


Non‑coding RNA: A promising diagnostic biomarker and therapeutic target for esophageal squamous cell carcinoma (Review).

Zhang L, Wang Y, Gao J, Zhou X, Huang M, Wang X Oncol Lett. 2024; 27(6):255.

PMID: 38646493 PMC: 11027111. DOI: 10.3892/ol.2024.14388.


promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating expression.

Chang Q, Zhou X, Mao H, Feng J, Wu X, Zhang Z Biomol Biomed. 2024; 24(5):1216-1230.

PMID: 38501918 PMC: 11379018. DOI: 10.17305/bb.2024.10247.


References
1.
Gupta B, Kumar N . Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev. 2016; 26(2):107-118. DOI: 10.1097/CEJ.0000000000000249. View

2.
Huang F, Yu S . Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2016; 41(3):210-215. DOI: 10.1016/j.asjsur.2016.10.005. View

3.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

4.
Hayes J, Peruzzi P, Lawler S . MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014; 20(8):460-9. DOI: 10.1016/j.molmed.2014.06.005. View

5.
Eichelmann A, Matuszcak C, Lindner K, Haier J, Hussey D, Hummel R . Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma. Sci Rep. 2018; 8(1):17553. PMC: 6277408. DOI: 10.1038/s41598-018-35799-1. View